Chemotherapeutic response in metastatic medulloblastoma: report of two cases and a review of the literature.
Metastatic medulloblastoma is a rare clinical phenomenon. Review of the literature and the authors' experience reveals that when it occurs, palliation may be achieved with a variety of single and combination chemotherapy programs. Two objective responses with vincristine-actinomycin-D-cyclophosphamide (VAC) and one each with adriamycin and methyl-CCNU are described.